Profile data is unavailable for this security.
About the company
International Stem Cell Corporation is a clinical-stage biotechnology company that is focused on therapeutic and biomedical product development. The Company is primarily a research and development company, for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central nervous system and liver diseases. The Company's products are based on human cell culture and a type of pluripotent stem cells and hpSCs. The Company's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC), which develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.
- Revenue in USD (TTM)7.83m
- Net income in USD-327.00k
- Incorporated2005
- Employees29.00
- LocationInternational Stem Cell Corp5950 Priestly DrCARLSBAD 92008-8849United StatesUSA
- Phone+1 (760) 940-6383
- Fax+1 (302) 636-5454
- Websitehttps://www.internationalstemcell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmagreen Biotech Inc | 1.56k | -500.66k | 597.28k | 0.00 | -- | -- | -- | 382.87 | -0.0011 | -0.0011 | 0.00 | -0.0045 | 0.0094 | -- | 3.35 | -- | -302.10 | -472.20 | -- | -- | 11.54 | -- | -32,096.15 | -- | 0.0194 | -71.71 | -- | -- | -- | -- | 80.68 | -- | -- | -- |
| Capstone Therapeutics Corp | 0.00 | -358.00k | 646.20k | 2.00 | -- | -- | -- | -- | -6.58 | -38.12 | 0.00 | -60.70 | 0.00 | -- | -- | -- | -113.46 | 141.94 | -199.60 | 173.06 | -- | -- | -- | -- | -- | -2.92 | -- | -- | -- | -- | 52.46 | -- | -- | -- |
| Bluejay Diagnostics Inc | 0.00 | -9.74m | 663.51k | 10.00 | -- | 0.058 | -- | -- | -61.41 | -61.41 | 0.00 | 10.02 | 0.00 | -- | -- | 0.00 | -122.06 | -- | -149.68 | -- | -- | -- | -- | -- | -- | -- | 0.0048 | -- | -100.00 | -- | -7.07 | -- | -- | -- |
| Molecular Pharmacology (USA) Ltd | 0.00 | -105.18k | 699.69k | 0.00 | -- | -- | -- | -- | -0.0009 | -0.0009 | 0.00 | -0.0188 | 0.00 | -- | -- | -- | -976.60 | -1,219.29 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 44.29 | -- | -- | -- |
| GRI Bio Inc | 0.00 | -12.77m | 760.76k | 4.00 | -- | 0.1107 | -- | -- | -349.68 | -349.68 | 0.00 | 11.38 | 0.00 | -- | -- | 0.00 | -382.23 | -192.93 | -869.57 | -353.99 | -- | -- | -- | -37,650.49 | -- | -16.80 | 0.00 | -- | -- | -- | -85.61 | -- | 29.46 | -- |
| International Stem Cell Corp | 7.83m | -327.00k | 784.43k | 29.00 | -- | -- | -- | 0.1002 | -0.0409 | -0.0409 | 0.9785 | 0.0045 | 1.46 | 2.53 | 11.87 | 270,069.00 | -5.81 | -29.22 | -68.13 | -73.82 | 58.58 | 59.49 | -3.97 | -21.01 | 0.4672 | -6.06 | 0.9898 | -- | -4.78 | -6.82 | 60.42 | -- | -34.45 | -- |
| Meso Numismatics Inc | 2.44m | -10.10m | 809.61k | 1.00 | -- | -- | -- | 0.3317 | -0.8113 | -0.8113 | 0.1959 | -1.90 | 0.438 | -- | 33.37 | -- | -181.33 | -192.08 | -- | -- | 69.97 | 60.24 | -413.98 | -821.49 | -- | -0.1106 | -- | -- | 57.49 | 116.97 | -76.03 | -- | 149.35 | -- |
| NovaBay Pharmaceuticals Inc | 14.23m | -18.43m | 944.10k | 24.00 | -- | -- | -- | 0.0663 | -108.80 | -108.97 | 50.49 | 0.1749 | 1.41 | 2.91 | 11.08 | 593,041.70 | -108.92 | -61.51 | -185.74 | -83.89 | 54.47 | 59.99 | -77.22 | -86.47 | 0.7462 | -- | 0.8629 | -- | 2.24 | 3.32 | -2.66 | -- | -15.46 | -- |
| Yield10 Bioscience Inc | 300.00k | -13.15m | 1.04m | 29.00 | -- | -- | -- | 3.47 | -146.30 | -146.30 | 1.06 | -123.90 | 0.0627 | -- | -- | 10,344.83 | -274.51 | -91.26 | -2,396.54 | -108.09 | -- | -- | -4,381.67 | -2,279.74 | -- | -- | -- | -- | -86.67 | -35.94 | -6.55 | -- | 1.84 | -- |
